top of page
Read • watch • learn
Welcome to the Hope Bio Blog
Hope Biosciences Announces Third FDA-approved Clinical Trial for COVID-19
This third clinical study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River Oaks Hospital and Clinics.
Hope Biosciences
Apr 21, 20202 min read
Hope Biosciences Receives Second FDA Clearance for a Phase II Clinical Trial for COVID-19
Allogeneic Mesenchymal Stem Cells for Frontline Workers to Provide Immune Support Against COVID-19 Hope Biosciences, a clinical stage...
Hope Biosciences
Apr 13, 20202 min read
FDA Approval to Commence First Stem Cell Clinical Trial for Protection Against COVID-19
HOUSTON, TX, April 06, 2020 – Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease, today announced that FDA has approved a Phase II clinical trial evaluating efficacy and safety of Hope Biosciences’ autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) to provide immune support against COVID-19. MSCs are well-known for their immunomodulatory and regenerative potential. In a recent Phase
Hope Biosciences
Apr 6, 20203 min read
bottom of page